
Senator Amy Klobuchar @SenAmyKlobuchar
Passed today: Klobuchar's bill to reduce incentives for drug companies to file sham petitions with the FDA to interfere with the approval of generics that would compete with their own products, a tactic that delays access to more affordable meds.#DrugCosts https://t.co/wcIpw1EovY — PolitiTweet.org